Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
Reproductive Medicine and Biology · 2024-01 · 23 (1)
DOI: 10.1002/rmb2.12573 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 25.03.2024. Verfasst von Shinnosuke Komiya und 4 weiteren Autor:innen. Beteiligte Einrichtung: HORAC Grand Front Osaka Clinic Osaka Japan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of follitropin δ and follitropin α/β.
Methods
We searched randomized controlled trials comparing follitropin δ and follitropin α/β using MEDLINE, Embase, CENTRAL, ClinicalTrials.gov , and WHO‐ITCRP on December 14, 2022. The primary outcomes were the live birth rate and the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS). The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation approach. The protocol was registered on the Open Science Framework.
Results
Three studies involving 2682 participants were included in our meta‐analysis. The results indicated that follitropin δ may result in little to no difference in live birth rates (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.91–1.38; low certainty) and the incidence of moderate or severe OHSS (RR, 0.78; 95% CI, 0.48–1.26; low certainty) compared with follitropin α/β.
Conclusion
Follitropin δ may result in little to no difference in COS compared with follitropin α/β, especially in terms of live births and safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- HORAC Grand Front Osaka Clinic Osaka Japan.
- Department of Obstetrics and Gynecology Kansai Medical University Graduate School of Medicine Hirakata, Osaka Japan.
- Systematic Review Workshop Peer Support Group (SRWS-PSG) Osaka Japan.
- Division of Gastroenterological, General and Transplant Surgery, Department of Surgery Jichi Medical University Shimotsuke Japan.
- Division of Community and Family Medicine Jichi Medical University Shimotsuke Japan.
- Division of Traumatology and Critical Care Medicine National Defense Medical College Saitama Japan.
ORCID-Profile: Shinnosuke Komiya, Kyosuke Kamijo, Hidetaka Okada
Zitieren
APA
Komiya, S., Watanabe, J., Terayama, T., Kamijo, K., & Okada, H. (2024). Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis. Reproductive Medicine and Biology, 23(1). https://doi.org/10.1002/rmb2.12573
Vancouver
Komiya S, Watanabe J, Terayama T, Kamijo K, Okada H. Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis. Reproductive Medicine and Biology. 2024;23(1). doi:10.1002/rmb2.12573
BibTeX
@article{Komiya2024,
author = {Komiya, Shinnosuke and Watanabe, Jun and Terayama, Takero and Kamijo, Kyosuke and Okada, Hidetaka},
title = {Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis},
journal = {Reproductive Medicine and Biology},
year = {2024},
volume = {23},
number = {1},
doi = {10.1002/rmb2.12573}
}
EUVIMED